Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Diseases

Explore clinical trials studying Fallopian Tube Diseases. Study availability and eligibility vary by location and protocol.

598 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Diseases trial results

Completed

Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial

NCT01506856

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
  • Queen Mary Hospital Hong Kong, High West
  • Aichi Cancer Center Hospital Chikusa, Aichi-ken, Japan
  • Hirosaki University School of Medicine & Hospital Hirosaki-shi, Aomori, Japan
View all 62 locations
View Trial Details
Completed

Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer

NCT00993655

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +33 more
Locations
  • Mercy-Springfield Springfield, Missouri, United States
  • CoxHealth Springfield, Missouri, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
  • Women and Infants Hospital of Rhode Island Providence, Rhode Island, United States
View all 50 locations
View Trial Details
Completed

A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

NCT04440943

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Urothelial Carcinoma, +61 more
Locations
  • Northside Hospital Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
  • Duke Cancer Center Durham, North Carolina, United States
View Trial Details
Completed

A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)

NCT01891344

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +26 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Saint Jude Heritage Medical Center Fullerton, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 75 locations
View Trial Details
Completed

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

NCT02855944

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +26 more
Locations
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Augusta University Augusta, Georgia, United States
  • Hospital Haroldo Juacaba Instituto do Cancer do Ceara Fortaleza, Ceará, Brazil
  • Instituto de Oncologia do Parana (IOP) Curitiba, Paraná, Brazil
View all 77 locations
View Trial Details
Completed

A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)

NCT01482715

Conditions
Adnexal Diseases, Advanced Solid Tumor With Evidence of Germline or Somatic BRCA, Disease Attributes, +22 more
Locations
  • UCSF San Francisco, California, United States
  • Sarah Cannon Research Institute Sarasota, Florida, United States
  • Dana-Farber Cancer Institute (Part 3 only) Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 16 locations
View Trial Details
Completed

Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)

NCT01968213

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Saint Jude Heritage Medical Center Fullerton, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
View all 96 locations
View Trial Details
Completed

A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)

NCT03657043

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Stanford Cancer Center South Bay San Jose, California, United States
  • Poudre Valley Health System (PVHS) Fort Collins, Colorado, United States
  • Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States
  • Miami Cancer Institute- Plantation (MCIP) Miami, Florida, United States
View all 37 locations
View Trial Details

Related conditions